Methane Sulfonic Acid Market Size, Share, Growth, and Industry Analysis, By Type (Medicine grade (99% purity),Industrial grade (70% purity),Others), By Application (Solvent,Pharmaceuticals,Pesticide,Others), Regional Insights and Forecast to 2035

Methane Sulfonic Acid Market Overview

The global Methane Sulfonic Acid Market size is projected to grow from USD 436.29 million in 2026 to USD 481.93 million in 2027, reaching USD 1068.27 million by 2035, expanding at a CAGR of 10.46% during the forecast period.

Methane sulfonic acid (MSA, CH₄O₃S) is a strong, non-oxidizing acid widely used in electroplating, pharmaceuticals, catalysts, and cleaning applications. Commercial grades are typically produced at 70% purity for industrial use and 99% purity for pharmaceutical applications. Global production facilities have installed capacities in the range of 10,000–20,000 tonnes per plant annually, with medium-sized producers manufacturing 1,000–5,000 tonnes per year. Industrial buyers commonly purchase bulk lots of 1,000–25,000 kg, while research and pharmaceutical companies procure smaller quantities of 25–500 kg. These capacity and usage patterns define the Methane Sulfonic Acid Market Size and Methane Sulfonic Acid Market Opportunities.

In the United States, annual demand for methane sulfonic acid is measured in the low thousands of tonnes, primarily driven by pharmaceuticals and electroplating industries. Medicine-grade MSA (≥99%) is used for drug salt formation, typically procured in 25–200 kg drums. Industrial grade (~70%) is purchased in larger lots, ranging from 1,000–20,000 kg per order, to support plating baths and surface finishing. More than 300–500 plating facilities across the U.S. use MSA-based electrolytes, while the pharmaceutical sector relies on MSA in 50+ FDA-approved mesylate-based APIs. This strong demand secures the USA’s role in Methane Sulfonic Acid Market Growth.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: Around 50% of demand is from substitution of hazardous acids, 40% from electroplating adoption, and 30% from pharmaceutical synthesis, making replacement of corrosive acids a leading growth factor.
• Major Market Restraint: Approximately 33% of producers face raw material availability issues, 25% cite regulatory delays, and 20% experience high cost of pharma-grade purification.
• Emerging Trends: About 45% of new demand comes from electronics plating, 35% from pharma salts, and 20% from green chemistry initiatives emphasizing sustainability.
• Regional Leadership: Asia-Pacific accounts for 40–50% of consumption, Europe 20–30%, North America 15–25%, and Middle East & Africa about 5–10%.
• Competitive Landscape: The top two global producers control 30–35% of supply, mid-tier producers account for 25%, while regional and smaller players cover 40%.
• Market Segmentation: Industrial grade (~70%) makes up 50–65% of volumes, medicine-grade (~99%) represents 20–30%, and other customized grades cover 5–15%.
• Recent Development: More than 150 new product SKUs were launched in 2023–2025, 200+ partnerships were signed, and at least 30% of capacity expansions targeted pharma-grade MSA.

Methane Sulfonic Acid Market Latest Trends

Current Methane Sulfonic Acid Market Trends highlight the shift toward replacing corrosive and hazardous acids with MSA. Electroplating industries now use MSA in more than 500+ facilities worldwide, with bath sizes containing 10–200 kg of MSA each. The pharmaceutical industry continues to expand its use of mesylate salts, with 50+ approved drugs globally requiring medicine-grade MSA in batch sizes from 10 kg clinical runs to 10,000+ kg commercial campaigns. Electronics manufacturing is another growth area, as more than 200 semiconductor and connector plants integrate MSA-based electrolytes, each consuming 100–1,000 kg annually. Green chemistry adoption is increasing, with 20–30% of new formulations highlighting low impurity and environmentally safer properties. Packaging options are also expanding, with drums (25–200 kg), IBCs (1,000–1,250 kg), and tankers (18–24 tonnes) offered across all regions. These usage patterns drive Methane Sulfonic Acid Market Outlook, with increasing emphasis on sustainable production, high-purity demand, and customized formulations across industries.

Methane Sulfonic Acid Market Dynamics

DRIVER

"Replacement of hazardous acids in industrial processes."

MSA has replaced nitric, fluoroboric, and perchloric acids in 30–40% of plating plants and 25–35% of pharmaceutical synthesis routes due to reduced corrosiveness and higher safety. Plating yields improve by 5–20% and waste disposal costs decrease by 10–40% with MSA substitution.

RESTRAINT

"High costs and limited raw material availability."

Pharma-grade MSA costs 10–50% more per kg than commodity acids. Around 33% of producers report delays in raw material supply, while 20% of pharma firms face qualification timelines extending 6–12 months, slowing Methane Sulfonic Acid Market Growth.

OPPORTUNITY

"Expansion in electronics and pharmaceuticals."

Electronics plating fabs consume 100–1,000 kg per bath annually, while pharma salt production averages 25–500 kg per batch with repeated campaigns. Over 100–150 new projects in Asia-Pacific and North America are underway, opening Methane Sulfonic Acid Market Opportunities.

CHALLENGE

"Market education and supply concentration."

More than 20–40% of potential users require pilot trials of 100–1,000 kg before adoption. Global production remains concentrated among fewer than 20 major producers, leading to regional shortages and lead times of 4–12 weeks for bulk shipments.

Methane Sulfonic Acid Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

Medicine grade (99% purity): Medicine-grade MSA (≥99.0% acidimetric purity) serves API salt formation and sensitive organic syntheses and typically accounts for 20–30% of market value terms and 10–20% of unit volumes. Pharma buyers order in discrete lots commonly between 25 kg drums and 1,000 kg IBCs per campaign, with clinical-to-commercial batch sizes spanning 10 kg to 10,000 kg depending on molecule scale. Critical specs include heavy metals <10 ppm, chloride/halide <5 ppm, water content <1%, and assay checks numbering 5–15 analytical tests per lot; supplier qualification cycles commonly take 3–12 months. Medicine-grade demand shows repeat purchase cadence of monthly to quarterly for active CDMOs and formulators, making this grade a strategic, high-margin segment in Methane Sulfonic Acid Market Analysis.

The Medicine Grade Methane Sulfonic Acid segment is projected to account for USD 150.12 million in 2025, representing 38% share, and is expected to reach USD 400.25 million by 2034, with a CAGR of 11.2%, fueled by increasing pharmaceutical applications.

Top 5 Major Dominant Countries in the Medicine Grade Segment

• United States includes USD 50.12 million in 2025, with 33.4% share and CAGR that includes 10.5%, driven by strong pharmaceutical manufacturing demand.
• Germany includes USD 30.02 million in 2025, with 20% share and CAGR that includes 10.8%, supported by chemical research and pharma industries.
• China includes USD 25.05 million in 2025, with 16.7% share and CAGR that includes 12.0%, fueled by domestic pharmaceutical production growth.
• Japan includes USD 20.01 million in 2025, with 13.3% share and CAGR that includes 9.8%, driven by high demand in medicine-grade applications.
• France includes USD 15.02 million in 2025, with 10% share and CAGR that includes 11.0%, supported by expanding pharma R&D activities.

Industrial grade (70% purity): Industrial-grade MSA (~70% w/w) is the dominant volume category, representing roughly 50–65% of global unit volumes and often shipped in bulk lots of 1,000–25,000 kg per order. Typical applications include electroplating baths, descaling, rust removal and general chemical processing; a medium-sized plating house operates 10–200 baths consuming 10–1,000 kg MSA per bath annually. Industrial specs often tolerate chloride and sulfate up to 100–1,000 ppm depending on use, and typical storage stability is 6–12 months under ambient conditions. Production footprints for industrial grade are larger many APAC plants report annual capacities of 1,000–20,000 tonnes driving competitive procurement dynamics and price-sensitive contracting in Methane Sulfonic Acid Market Size.

Industrial Grade Methane Sulfonic Acid is estimated at USD 200.50 million in 2025, holding 50.8% share, and expected to reach USD 470.15 million by 2034, with a CAGR of 9.9%, driven by applications in electroplating and chemical synthesis.

Top 5 Major Dominant Countries in the Industrial Grade Segment

• China includes USD 70.15 million in 2025, with 35% share and CAGR that includes 10.5%, fueled by rapid industrial adoption.
• United States includes USD 50.12 million in 2025, with 25% share and CAGR that includes 9.8%, supported by chemical industry utilization.
• Germany includes USD 30.10 million in 2025, with 15% share and CAGR that includes 10.0%, driven by industrial manufacturing applications.
• South Korea includes USD 25.08 million in 2025, with 12.5% share and CAGR that includes 10.2%, supported by electroplating and manufacturing demand.
• India includes USD 25.05 million in 2025, with 12.5% share and CAGR that includes 11.0%, fueled by expanding chemical and industrial sectors.

Others: “Other” grades include diluted MSA solutions (e.g., 30–50%), low-impurity electronics blends (<1 ppm specific contaminants), and premixed cleaning formulations (e.g., 1–10% active MSA). This bucket represents 5–15% of units and is important for R&D, pilot lines and niche end-uses; lab orders for these grades range from 0.1–100 kg, pilot orders of 100–1,000 kg, and small commercial batches of 1,000–10,000 kg. Specialty packaging options drums (25–200 kg), IBCs (1,000–1,250 kg), and ISO tankers (18–24 tonnes) are common. Typical quality control for specialty lots includes 10–30 parameter assays, and turnaround times for bespoke grades can be 2–8 weeks, influencing procurement lead-time planning in Methane Sulfonic Acid Market Segmentation.

The Others segment is projected at USD 44.36 million in 2025, holding 11.2% share, and is expected to reach USD 96.71 million by 2034, with a CAGR of 9.6%, driven by niche chemical and research applications.

Top 5 Major Dominant Countries in the Others Segment

• United States includes USD 15.02 million in 2025, with 33.8% share and CAGR that includes 10.0%, supported by research and specialty chemical applications.
• Germany includes USD 10.01 million in 2025, with 22.5% share and CAGR that includes 9.8%, driven by laboratory chemical usage.
• China includes USD 8.05 million in 2025, with 18.2% share and CAGR that includes 10.5%, fueled by small-scale chemical industries.
• Japan includes USD 6.08 million in 2025, with 13.7% share and CAGR that includes 9.5%, driven by pharmaceutical research demand.
• South Korea includes USD 5.20 million in 2025, with 11.7% share and CAGR that includes 9.9%, supported by niche chemical and industrial uses.

BY APPLICATION

Solvent / catalyst: As a polar acidic solvent and catalyst, MSA is employed in esterification, alkylation, polymerization and other specialty syntheses, accounting for 20–30% of application-based demand in many chemical producers’ portfolios. Lab and bench chemists use 0.1–100 kg per run; pilot plants use 100–1,000 kg, and commercial reactors consume 1,000–10,000+ kg per campaign. Concentrated MSA (≥70%) is common for catalytic stoichiometries; dosing is precisely controlled using acidimetric normality and density (concentrated MSA density ≈ 1.48 g/mL). Adoption in solvent/catalyst roles often results in repeat purchases every weeks to months, making solvent-grade MSA an operationally critical segment in Methane Sulfonic Acid Market Applications.

The Solvent segment is projected at USD 120.45 million in 2025, with a CAGR of 10.3%, driven by increasing industrial and chemical process usage.

Top 5 Major Dominant Countries in Solvent Application

• China includes USD 45.12 million in 2025, with 37.5% share and CAGR that includes 11.0%, fueled by industrial chemical applications.
• United States includes USD 25.05 million in 2025, with 20.8% share and CAGR that includes 10.0%, driven by manufacturing demand.
• Germany includes USD 20.02 million in 2025, with 16.6% share and CAGR that includes 10.5%, supported by chemical process utilization.
• South Korea includes USD 15.10 million in 2025, with 12.5% share and CAGR that includes 10.2%, fueled by electroplating and industrial processes.
• Japan includes USD 15.16 million in 2025, with 12.6% share and CAGR that includes 9.8%, driven by solvent demand in specialty chemicals.

Pharmaceuticals: Pharmaceutical applications are a high-value segment medicine-grade MSA is used to form mesylate salts that improve API solubility and stability; this application represents 20–30% of demand by value. Clinical and commercial batch sizes vary: clinical trial lots often run 10–500 kg, scale-up campaigns 500–10,000+ kg. Regulatory requirements necessitate supplier qualification, COA provision, and impurity profiling with heavy metal limits often below 10 ppm; many pharmaceutical purchasers maintain 3–6 qualified sources. Turnover cadence for pharma CDMOs and API manufacturers typically runs monthly to quarterly, with long-term contracts spanning 1–5 years for stable supply, driving procurement dynamics in Methane Sulfonic Acid Market Analysis.

Pharmaceutical applications are estimated at USD 150.12 million in 2025, with a CAGR of 11.2%, driven by rising medicine-grade Methane Sulfonic Acid use in drug formulation and R&D.

Top 5 Major Dominant Countries in Pharmaceuticals Application

• United States includes USD 50.12 million in 2025, with 33.4% share and CAGR that includes 11.0%, supported by pharmaceutical manufacturing demand.
• Germany includes USD 30.02 million in 2025, with 20% share and CAGR that includes 10.8%, driven by R&D and pharma applications.
• China includes USD 25.05 million in 2025, with 16.7% share and CAGR that includes 12.0%, fueled by domestic pharma growth.
• Japan includes USD 20.01 million in 2025, with 13.3% share and CAGR that includes 9.8%, supported by high medicine-grade demand.
• France includes USD 15.02 million in 2025, with 10% share and CAGR that includes 11.0%, driven by pharmaceutical sector demand.

Pesticide / agrochemical: In agrochemical synthesis, MSA functions as an intermediate, catalyst or formulation aid in certain esterification and amidation routes; the pesticide/agrochemical segment accounts for roughly 10–20% of consumption in chemical manufacturing regions. Industrial campaigns typically consume 100–10,000 kg per product line; formulation houses may include small mass fractions (<5%) of MSA in spray adjuvants prepared in 1,000–100,000 litre batches. Regulatory and residue requirements in agro markets require trace analysis for downstream product registration; pilot adoption often involves 100–1,000 kg trials before multi-ton production, creating staged procurement cycles and Methane Sulfonic Acid Market Opportunity windows for suppliers serving agrochemical manufacturers.

The Pesticide segment is estimated at USD 80.25 million in 2025, growing at a CAGR of 10.1%, driven by rising agricultural chemical usage.

Top 5 Major Dominant Countries in Pesticide Application

• India includes USD 25.08 million in 2025, with 31.2% share and CAGR that includes 11.0%, fueled by agrochemical demand.
• China includes USD 20.15 million in 2025, with 25.1% share and CAGR that includes 10.5%, driven by large-scale agriculture.
• United States includes USD 15.12 million in 2025, with 18.8% share and CAGR that includes 9.8%, supported by chemical pesticide usage.
• Brazil includes USD 10.10 million in 2025, with 12.6% share and CAGR that includes 10.2%, fueled by agricultural growth.
• Germany includes USD 9.90 million in 2025, with 12.3% share and CAGR that includes 10.0%, driven by agrochemical demand.

Others: Other uses collectively represent 10–25% of unit volumes and include metal cleaning, descaling, resin synthesis and electronics finishing. Small foundries and maintenance shops typically use 10–1,000 kg lots for cleaning operations, while plating and connector manufacturers may operate 10–1,000 baths, each consuming 10–1,000 kg of MSA annually. Electronics fabs require ultra-low impurity grades in select rinses or plating steps with consumption ranges of 100–5,000 kg per site per year. Resin and specialty polymer producers use MSA as a catalyst in batch sizes from 100–10,000+ kg, and many industrial buyers keep buffer inventories equal to 1–3 months of normal usage to manage supply variability important operational parameters for Methane Sulfonic Acid Market Segmentation and sourcing strategies.

The Others application segment is projected at USD 44.36 million in 2025, with a CAGR of 9.6%, driven by miscellaneous chemical and research applications.

Top 5 Major Dominant Countries in Others Application

• United States includes USD 15.02 million in 2025, with 33.8% share and CAGR that includes 10.0%, fueled by research applications.
• Germany includes USD 10.01 million in 2025, with 22.5% share and CAGR that includes 9.8%, supported by specialty chemical usage.
• China includes USD 8.05 million in 2025, with 18.2% share and CAGR that includes 10.5%, driven by industrial chemical demand.
• Japan includes USD 6.08 million in 2025, with 13.7% share and CAGR that includes 9.5%, fueled by pharmaceutical research.
• South Korea includes USD 5.20 million in 2025, with 11.7% share and CAGR that includes 9.9%, supported by niche chemical applications.

Methane Sulfonic Acid Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

NORTH AMERICA

North America holds 15–25% of global Methane Sulfonic Acid Market Share. The USA is the largest consumer, with 300–500 plating facilities and 50+ pharma firms using MSA in salt synthesis. Typical pharma lots are 25–1,000 kg, while plating facilities require 100–10,000 kg annually per site. Supply is limited, with imports covering 30–40% of demand and lead times of 2–8 weeks.

The North America Methane Sulfonic Acid market is valued at USD 80.12 million in 2025, with 20.28% share, expected to reach USD 185.30 million by 2034, growing at a CAGR of 10.2%, driven by pharmaceutical and industrial usage.

North America - Major Dominant Countries

• United States includes USD 60.10 million in 2025, with 75% share and CAGR that includes 10.3%, driven by medicine-grade demand.
• Canada includes USD 12.05 million in 2025, with 15% share and CAGR that includes 10.0%, supported by chemical and industrial sectors.
• Mexico includes USD 5.02 million in 2025, with 6.3% share and CAGR that includes 9.8%, fueled by industrial demand.
• Puerto Rico includes USD 2.02 million in 2025, with 2.5% share and CAGR that includes 10.1%, driven by specialty chemical use.
• Others include USD 1.03 million in 2025, with 1.3% share and CAGR that includes 9.9%, supported by miscellaneous applications.

EUROPE

Europe contributes 20–30% of consumption, led by 10–25 major countries adopting MSA in plating and pharmaceuticals. Pharma campaigns use 10–10,000 kg annually, while plating houses run 50–500 baths consuming 10–1,000 kg per bath. EU environmental rules incentivize MSA substitution, boosting demand.

The Europe Methane Sulfonic Acid market is estimated at USD 90.15 million in 2025, with 22.82% share, projected to reach USD 225.45 million by 2034, at a CAGR of 10.5%, supported by pharmaceutical and chemical sectors.

Europe - Major Dominant Countries

• Germany includes USD 35.12 million in 2025, with 38.9% share and CAGR that includes 10.8%, driven by industrial and pharma applications.
• France includes USD 20.10 million in 2025, with 22.3% share and CAGR that includes 11.0%, supported by medicine-grade demand.
• Italy includes USD 15.05 million in 2025, with 16.7% share and CAGR that includes 10.2%, fueled by chemical industries.
• United Kingdom includes USD 12.02 million in 2025, with 13.3% share and CAGR that includes 10.0%, driven by research applications.
• Spain includes USD 8.86 million in 2025, with 9.8% share and CAGR that includes 9.9%, supported by specialty chemical demand.

ASIA-PACIFIC

Asia-Pacific dominates with 40–50% of volumes, driven by China, India, and South Korea. China operates dozens of plants producing 1,000–20,000 tonnes annually, while India consumes 100–500 kg per pharma batch. Electronics fabs consume 100–1,000 kg per bath annually, reinforcing APAC’s leadership.

The Asia Methane Sulfonic Acid market is valued at USD 150.25 million in 2025, holding 38.03% share, expected to reach USD 370.45 million by 2034, with a CAGR of 10.9%, driven by China and India industrial and pharmaceutical demand.

Asia - Major Dominant Countries

• China includes USD 60.15 million in 2025, with 40% share and CAGR that includes 11.0%, supported by industrial and pharma applications.
• India includes USD 35.12 million in 2025, with 23.4% share and CAGR that includes 11.5%, fueled by agrochemical and industrial demand.
• Japan includes USD 25.05 million in 2025, with 16.7% share and CAGR that includes 10.2%, driven by medicine-grade usage.
• South Korea includes USD 15.02 million in 2025, with 10% share and CAGR that includes 10.0%, supported by industrial applications.
• Taiwan includes USD 15.01 million in 2025, with 10% share and CAGR that includes 9.8%, fueled by chemical and pharmaceutical sectors.

MIDDLE EAST & AFRICA

MEA accounts for 5–10% of demand, focused on descaling and cleaning in petrochemical plants. Facilities consume 100–1,000 kg annually, with imports arriving in lots of 10–24 tonnes. Procurement cycles average 3–8 weeks, and demand is expected to rise 5–15% annually with new projects.

The Middle East and Africa Methane Sulfonic Acid market is projected at USD 74.46 million in 2025, holding 18.83% share, expected to reach USD 186.00 million by 2034, with a CAGR of 10.1%, driven by industrial and chemical demand.

Middle East and Africa - Major Dominant Countries

• Saudi Arabia includes USD 25.02 million in 2025, with 33.6% share and CAGR that includes 10.2%, driven by industrial applications.
• South Africa includes USD 20.05 million in 2025, with 26.9% share and CAGR that includes 10.0%, supported by chemical manufacturing.
• UAE includes USD 15.12 million in 2025, with 20.3% share and CAGR that includes 10.5%, fueled by specialty chemicals demand.
• Egypt includes USD 10.08 million in 2025, with 13.5% share and CAGR that includes 10.3%, driven by industrial growth.
• Others includes USD 4.19 million in 2025, with 5.7% share and CAGR that includes 9.8%, supported by miscellaneous applications.

List of Top Methane Sulfonic Acid Companies

• Hubei Xingchi
• Taizhou Sunny Chemical
• Dexing Zhongke Fine Chemical
• BASF Group
• Langfang Jinshenghui Chemical
• Sipcam Oxon
• Arkema Group

BASF Group: Global producer with annual capacity in the 10,000s of tonnes, supplying both pharma and industrial grades.

Arkema Group: Manufactures industrial (70%) and medicine-grade (99%) MSA, distributing to 20+ countries with batch sizes from 100 kg to 25 tonnes.

Investment Analysis and Opportunities

Recent investments focus on expanding high-purity production lines, with new facilities adding 1,000–10,000 tonnes annually. Pharma salt production offers recurring opportunities, with contract campaigns using 25–500 kg per batch and requiring long-term supply agreements. Electronics fabs with 10–100 baths per site consume 100–1,000 kg each, offering stable recurring demand. Warehousing strategies with 1–3 month stocks reduce lead times and capture premium pricing. Investments in 20–30% cleaner processes and improved SO₃ handling technologies reduce environmental footprints, appealing to sustainability-focused buyers.

New Product Development

Between 2023–2025, manufacturers launched 50–150 new SKUs, including ≥99% pharma-grade, 70% industrial grade, and premixed cleaning solutions. Certificates of Analysis now include 10–30 parameters, covering metals (<10 ppm) and halides (<5 ppm). Electronics-grade blends were introduced with impurity levels <1 ppm, supporting microchip plating. Cleaning formulations with 1–10% MSA reduce cycle times by 50–70%, saving hours per maintenance run.

Five Recent Developments

• 150+ new product SKUs introduced across purity ranges.
• 10–20% expansion in Asian production capacity for industrial grades.
• 200+ partnerships signed with pharma and plating firms.
• Electronics fabs scaled from 10 to 100+ baths using MSA electrolytes.
• Premixed 1–10% cleaning solutions launched, cutting maintenance time by 50%.

Report Coverage of Methane Sulfonic Acid Market

The Methane Sulfonic Acid Market Research Report covers type (medicine-grade, industrial-grade, customized), application (pharma, electroplating, solvents, pesticides, others), and regional demand shares: Asia-Pacific 40–50%, Europe 20–30%, North America 15–25%, and MEA 5–10%. Procurement lot sizes range from 25–200 kg drums to 18–24 tonne tankers, with lead times averaging 2–8 weeks for imports. Quality requirements include heavy metals <10 ppm, halides <5 ppm, and acidimetric purity ≥99% for pharma. Industrial users focus on 70% grades for plating, typically ordering 1,000–25,000 kg per batch. The report highlights investment indicators, with 1,000–10,000 tonne expansions underway and sustainability initiatives reducing emissions by 20–50%.

Methane Sulfonic Acid Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 436.29 Million in 2026
Market Size Value By	USD 1068.27 Million by 2035
Growth Rate	CAGR of 10.46% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Medicine grade (99% purity) Industrial grade (70% purity) Others By Application : Solvent Pharmaceuticals Pesticide Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample